Research and Markets has announced the addition of the "Lung Cancer: Analytical Tool" report to their offering.
Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.
It covers more than 553 companies plus partners who are today developing 1130 lung cancer drugs where of 809 are active in 884 developmental projects in cancer across 435 different targets. The Analytical Tool and its contents are yours to keep and data can be easily exported into Excel format for mixing with your own proprietary information.
The Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:
For more information about this report visit http://www.researchandmarkets.com/research/ks69js/lung_cancer
Related Topics: Lung Cancer Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160919005546/en/Business Wire
Last updated on: 19/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.